معرفی
Ashley Hawarden is a Versus Arthritis Clinical Research Fellow and NIHR-funded Academic Clinical Fellow in Rheumatology at Keele University's School of Medicine. He holds a medical degree from Keele University (2014) and an intercalated Master's in Medical Education. His clinical training occurs at Haywood Hospital, Stoke-on-Trent, while his research focuses on osteoporosis management in primary care, including barriers to evidence-based practice and clinician training needs. He is part of the Keele Osteoporosis Research Group led by Dr. Zoe Paskins.
Education:
- Bachelor of Medicine, Keele University School of Medicine (2014)
- Intercalated Master's in Medical Education (during medical studies)
Research Interests: Ashley's work addresses osteoporosis identification, investigation, and management in primary care. He investigates clinical decision-making, shared patient-provider practices, and interventions to improve adherence to osteoporosis treatments. His studies often employ mixed-methods approaches, combining qualitative insights with randomized controlled trials.
Key Contributions: His publications explore topics such as fracture liaison service improvements, shared decision-making frameworks, and the impact of nurse-led care models. He has contributed to national guidelines on osteoporosis patient information quality and evaluated vaccine efficacy in inflammatory arthritis patients.
Grants & Awards:
- NIHR Academic Clinical Fellowship in Rheumatology (2018–2021)
- Versus Arthritis Clinical Research Fellowship (2022–present)
Labs/Teams: Member of the Keele Osteoporosis Research Group, collaborating with NHS Trusts to advance fracture prevention strategies. Active in educational research through Keele's Clinical Education Centre.
